PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials
Year: 2017
Type: review
Source: Pharmacology & Therapeutics
Authors: Nandini Dey, Pradip De, Brian Leyland-Jones
Institutions: University of South Dakota, Avera Health
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2589036504
